BRCA1 and cancer: Compared to the full-length BRCA1 spliceosome, BRCA1--Δ11q clearly promotes cancer cell growth as well as resistance to PARP inhibitors and cisplatin (Nielsen et al., 2016; Wang et al., 2016).